Jump to content

Search results

  • Thumbnail for Actelion
    "Thomson Reuters ONE". Actelion Receives Swissmedic Approval for Uptravi (Selexipag) for Treatment of Pulmonary Arterial Hypertension. COMTEX News Network...
    25 KB (2,589 words) - 03:31, 21 May 2024